3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
115
Gliosarcoma
53
Brain Neoplasms
53
Glioma
47
Central Nervous System Neoplasms
30
Astrocytoma
29
Melanoma
26
Oligodendroglioma
14
Neuroblastoma
10
Neoplasm Metastasis
9
Recurrence
7
Ependymoma
7
Sarcoma
6
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Skin Neoplasms
5
Sarcoma, Ewing
5
Lymphoma
5
Breast Neoplasms
5
Spinal Cord Neoplasms
4
Somatostatinoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Colorectal Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Gastrinoma
3
Carcinoma, Islet Cell
3
Uveal Melanoma
2
Rhabdomyosarcoma
2
Interventions
Paclitaxel
57
Carboplatin
51
Bevacizumab
41
Taxes
28
liposomal doxorubicin
21
Gemcitabine
19
Immunoglobulin G
17
Disulfides
17
pembrolizumab
15
Topotecan
12
rucaparib
10
Cyclophosphamide
9
Cisplatin
9
Docetaxel
8
olaparib
7
Doxorubicin
7
pazopanib
6
mirvetuximab soravtansine
6
cediranib
6
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
sargramostim
4
niraparib
4
Surgical Procedures, Operative
4
Drug Therapy
4
Cytoreduction Surgical Procedures
4
Albumin-Bound Paclitaxel
4
veliparib
3
fludarabine phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Fallopian Tube Neoplasms
×
Temozolomide
×
Clear all
No trials found.